The potent analgesia of intrathecal 2R, 6R-HNK via TRPA1 inhibition in LF-PENS-induced chronic primary pain model

[1]  L. Vécsei,et al.  TRP Channels: Recent Development in Translational Research and Potential Therapeutic Targets in Migraine , 2022, International journal of molecular sciences.

[2]  D. Hay,et al.  CGRP physiology, pharmacology, and therapeutic targets: Migraine and beyond. , 2022, Physiological reviews.

[3]  K. Manda,et al.  Intranasal (2R, 6R)‐hydroxynorketamine for acute pain: Behavioural and neurophysiological safety analysis in mice , 2022, Clinical and experimental pharmacology & physiology.

[4]  I. Lucki,et al.  (2R,6R)-hydroxynorketamine (HNK) reverses mechanical hypersensitivity in a model of localized inflammatory pain , 2022, Neuropharmacology.

[5]  Guoqing Guo,et al.  Social defeat drives hyperexcitation of the piriform cortex to induce learning and memory impairment but not mood-related disorders in mice , 2022, Translational Psychiatry.

[6]  I. Lucki,et al.  Antinociceptive and Analgesic Effects of (2R,6R)-Hydroxynorketamine , 2022, The Journal of Pharmacology and Experimental Therapeutics.

[7]  T. Yaksh,et al.  Intrathecal Drug Delivery: Advances and Applications in the Management of Chronic Pain Patient , 2022, Frontiers in Pain Research.

[8]  D. Dodick,et al.  Dysregulation of serum prolactin links the hypothalamus with female nociceptors to promote migraine. , 2022, Brain : a journal of neurology.

[9]  Mark I. Johnson,et al.  Efficacy and safety of transcutaneous electrical nerve stimulation (TENS) for acute and chronic pain in adults: a systematic review and meta-analysis of 381 studies (the meta-TENS study) , 2022, BMJ Open.

[10]  Sara J. Shnider,et al.  A Monoclonal Anti–Calcitonin Gene-Related Peptide Antibody Decreases Stress-Induced Colonic Hypersensitivity , 2021, The Journal of Pharmacology and Experimental Therapeutics.

[11]  B. Ohlsson.  Theories behind the effect of starch- and sucrose-reduced diets on gastrointestinal symptoms in irritable bowel syndrome , 2021, Molecular medicine reports.

[12]  Flavia Laffleur,et al.  Progress in nasal drug delivery systems. , 2021, International journal of pharmaceutics.

[13]  L. De Baets,et al.  Nociplastic Pain Criteria or Recognition of Central Sensitization? Pain Phenotyping in the Past, Present and Future , 2021, Journal of clinical medicine.

[14]  S. M. Oliveira,et al.  Animal models of fibromyalgia: What is the best choice? , 2021, Pharmacology & therapeutics.

[15]  Steven P. Cohen,et al.  Nociplastic pain: towards an understanding of prevalent pain conditions , 2021, The Lancet.

[16]  T. Gould,et al.  Hydroxynorketamines: Pharmacology and Potential Therapeutic Applications , 2021, Pharmacological Reviews.

[17]  R. Deichmann,et al.  Central encoding of the strength of intranasal chemosensory trigeminal stimuli in a human experimental pain setting , 2020, Human brain mapping.

[18]  T. Kuner,et al.  Cellular circuits in the brain and their modulation in acute and chronic pain. , 2020, Physiological reviews.

[19]  D. Julius,et al.  Irritant-evoked activation and calcium modulation of the TRPA1 receptor , 2020, Nature.

[20]  Hailan Hu,et al.  Circuits and functions of the lateral habenula in health and in disease , 2020, Nature Reviews Neuroscience.

[21]  B. Nilius,et al.  Mammalian transient receptor potential TRPA1 channels: from structure to disease. , 2020, Physiological reviews.

[22]  V. Neugebauer,et al.  Amygdala, neuropeptides, and chronic pain-related affective behaviors , 2020, Neuropharmacology.

[23]  M. Barrot,et al.  How to study anxiety and depression in rodent models of chronic pain? , 2020, The European journal of neuroscience.

[24]  R. Traub,et al.  The Role of Descending Pain Modulation in Chronic Primary Pain: Potential Application of Drugs Targeting Serotonergic System , 2019, Journal of Neural Transplantation and Plasticity.

[25]  M. Borgnia,et al.  Structural Insights into Electrophile Irritant Sensing by the Human TRPA1 Channel , 2019, Neuron.

[26]  K. Medzihradszky,et al.  A Cell-Penetrating Scorpion Toxin Enables Mode-Specific Modulation of TRPA1 and Pain , 2019, Cell.

[27]  S. Thompson,et al.  (R)‐Ketamine exerts antidepressant actions partly via conversion to (2R,6R)‐hydroxynorketamine, while causing adverse effects at sub‐anaesthetic doses , 2019, British journal of pharmacology.

[28]  A. Gardier,et al.  Fast-acting antidepressant activity of ketamine: highlights on brain serotonin, glutamate, and GABA neurotransmission in preclinical studies. , 2019, Pharmacology & therapeutics.

[29]  Ukpong B. Eyo,et al.  Microglia Are Indispensable for Synaptic Plasticity in the Spinal Dorsal Horn and Chronic Pain. , 2019, Cell reports.

[30]  J. Kehr,et al.  Antidepressant-relevant concentrations of the ketamine metabolite (2R,6R)-hydroxynorketamine do not block NMDA receptor function , 2019, Proceedings of the National Academy of Sciences.

[31]  Loren J. Martin,et al.  Genetic pathway analysis reveals a major role for extracellular matrix organization in inflammatory and neuropathic pain , 2019, Pain.

[32]  Sheng Wang,et al.  Effects of TRPA1 activation and inhibition on TRPA1 and CGRP expression in dorsal root ganglion neurons , 2019, Neural regeneration research.

[33]  Michael B. First,et al.  Chronic pain as a symptom or a disease: the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11) , 2019, Pain.

[34]  R. Benoliel,et al.  The IASP classification of chronic pain for ICD-11: chronic primary pain , 2019, Pain.

[35]  J. Kroin,et al.  Efficacy of the ketamine metabolite (2R,6R)-hydroxynorketamine in mice models of pain , 2018, Regional Anesthesia & Pain Medicine.

[36]  D. Swaab,et al.  The human hypothalamus in mood disorders: The HPA axis in the center , 2018, IBRO reports.

[37]  M. Zhuo,et al.  Heterosynaptic long-term potentiation from the anterior cingulate cortex to spinal cord in adult rats , 2018, Molecular pain.

[38]  C. Tassorelli,et al.  Chronic and intermittent administration of systemic nitroglycerin in the rat induces an increase in the gene expression of CGRP in central areas: potential contribution to pain processing , 2018, The Journal of Headache and Pain.

[39]  T. Gould,et al.  Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms , 2018, Pharmacological Reviews.

[40]  Shih-Pin Chen,et al.  Animal Models of Chronic Migraine , 2018, Current Pain and Headache Reports.

[41]  E. Kalso,et al.  Interactions of (2S,6S;2R,6R)‐Hydroxynorketamine, a Secondary Metabolite of (R,S)‐Ketamine, with Morphine , 2018, Basic & clinical pharmacology & toxicology.

[42]  T. Gould,et al.  Mechanisms of ketamine action as an antidepressant , 2018, Molecular Psychiatry.

[43]  A. May,et al.  Cluster headache , 2018, Nature Reviews Disease Primers.

[44]  C. Denny,et al.  Common Neurotransmission Recruited in (R,S)-Ketamine and (2R,6R)-Hydroxynorketamine–Induced Sustained Antidepressant-like Effects , 2017, Biological Psychiatry.

[45]  Irina Vetter,et al.  Methods Used to Evaluate Pain Behaviors in Rodents , 2017, Front. Mol. Neurosci..

[46]  K. Hashimoto,et al.  Antidepressant Potential of (R)-Ketamine in Rodent Models: Comparison with (S)-Ketamine , 2017, The Journal of Pharmacology and Experimental Therapeutics.

[47]  P. Durham,et al.  Elevated levels of calcitonin gene-related peptide in upper spinal cord promotes sensitization of primary trigeminal nociceptive neurons , 2016, Neuroscience.

[48]  J. Sandkühler,et al.  Gliogenic LTP spreads widely in nociceptive pathways , 2016, Science.

[49]  A. Shackman,et al.  Contributions of the Central Extended Amygdala to Fear and Anxiety , 2016, The Journal of Neuroscience.

[50]  Keith Matthews,et al.  A causal role for the anterior mid-cingulate cortex in negative affect and cognitive control. , 2016, Brain : a journal of neurology.

[51]  Xi-Ping Huang,et al.  NMDAR inhibition-independent antidepressant actions of ketamine metabolites , 2016, Nature.

[52]  Zhen Qin,et al.  Clinical study of cerebrospinal fluid neuropeptides in patients with primary trigeminal neuralgia , 2016, Clinical Neurology and Neurosurgery.

[53]  R. Morland,et al.  Enhanced c‐Fos expression in the central amygdala correlates with increased thigmotaxis in rats with peripheral nerve injury , 2016, European journal of pain.

[54]  K. Iwata,et al.  Involvement of peripheral artemin signaling in tongue pain: possible mechanism in burning mouth syndrome , 2015, Pain.

[55]  R. Carr,et al.  Assessment of TTX-s and TTX-r Action Potential Conduction along Neurites of NGF and GDNF Cultured Porcine DRG Somata , 2015, PloS one.

[56]  M. Sanghvi,et al.  The distribution and clearance of (2S,6S)-hydroxynorketamine, an active ketamine metabolite, in Wistar rats , 2015, Pharmacology research & perspectives.

[57]  Mark I. Johnson,et al.  Transcutaneous electrical nerve stimulation for acute pain. , 2015, The Cochrane database of systematic reviews.

[58]  P. Pitychoutis,et al.  Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-naïve and “depressed” mice exposed to chronic mild stress , 2015, Neuroscience.

[59]  M. Barrot,et al.  The Anterior Cingulate Cortex Is a Critical Hub for Pain-Induced Depression , 2015, Biological Psychiatry.

[60]  Li-Jun Zhou,et al.  Long-term potentiation at spinal C-fiber synapses: a target for pathological pain. , 2014, Current pharmaceutical design.

[61]  K. Kullander,et al.  Multimodal Use of Calcitonin Gene-Related Peptide and Substance P in Itch and Acute Pain Uncovered by the Elimination of Vesicular Glutamate Transporter 2 from Transient Receptor Potential Cation Channel Subfamily V Member 1 Neurons , 2014, The Journal of Neuroscience.

[62]  Anke Tappe-Theodor,et al.  Studying ongoing and spontaneous pain in rodents – challenges and opportunities , 2014, The European journal of neuroscience.

[63]  G. Zeni,et al.  Depression-related behavior and mechanical allodynia are blocked by 3-(4-fluorophenylselenyl)-2,5-diphenylselenophene in a mouse model of neuropathic pain induced by partial sciatic nerve ligation , 2014, Neuropharmacology.

[64]  T. Buhl,et al.  A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1. , 2014, The Journal of allergy and clinical immunology.

[65]  M. Atalay,et al.  Cortical spreading depression induces oxidative stress in the trigeminal nociceptive system , 2013, Neuroscience.

[66]  Michel Boulouard,et al.  Object recognition test in mice , 2013, Nature Protocols.

[67]  A. Pertovaara,et al.  Pronociception from the dorsomedial nucleus of the hypothalamus is mediated by the rostral ventromedial medulla in healthy controls but is absent in arthritic animals , 2013, Brain Research Bulletin.

[68]  P. Martínez-Camblor,et al.  Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine , 2013, Neurology.

[69]  R. Malinow,et al.  βCaMKII in Lateral Habenula Mediates Core Symptoms of Depression , 2013, Science.

[70]  M. Kabbaj,et al.  Sex differences in the antidepressant-like effects of ketamine , 2013, Neuropharmacology.

[71]  C. Zarate,et al.  Sub-anesthetic concentrations of (R,S)-ketamine metabolites inhibit acetylcholine-evoked currents in α7 nicotinic acetylcholine receptors. , 2013, European journal of pharmacology.

[72]  K. Kullander,et al.  VGLUT2-dependent glutamatergic transmission in primary afferents is required for intact nociception in both acute and persistent pain modalities , 2012, PAIN.

[73]  J. Sandkühler,et al.  Heterosynaptic Long-Term Potentiation at GABAergic Synapses of Spinal Lamina I Neurons , 2011, The Journal of Neuroscience.

[74]  M. Truin,et al.  Successful pain relief in non‐responders to spinal cord stimulation: The combined use of ketamine and spinal cord stimulation , 2011, European journal of pain.

[75]  Xin-Fu Zhou,et al.  Biphasic Activation of Extracellular Signal-regulated Kinase in Anterior Cingulate Cortex Distinctly Regulates the Development of Pain-related Anxiety and Mechanical Hypersensitivity in Rats after Incision , 2011, Anesthesiology.

[76]  E. Kavalali,et al.  NMDA Receptor Blockade at Rest Triggers Rapid Behavioural Antidepressant Responses , 2011, Nature.

[77]  Yang Liu,et al.  VGLUT2-Dependent Glutamate Release from Nociceptors Is Required to Sense Pain and Suppress Itch , 2010, Neuron.

[78]  K. Kullander,et al.  VGLUT2-Dependent Sensory Neurons in the TRPV1 Population Regulate Pain and Itch , 2010, Neuron.

[79]  M. Grafe,et al.  Effects of Intrathecal Ketamine in the Neonatal Rat: Evaluation of Apoptosis and Long-term Functional Outcome , 2010, Anesthesiology.

[80]  Justin S. Cetas,et al.  A possible neural basis for stress-induced hyperalgesia , 2009, PAIN®.

[81]  Xiao-Hua Cao,et al.  Activation of Extracellular Signal-Regulated Kinase in the Anterior Cingulate Cortex Contributes to the Induction and Expression of Affective Pain , 2009, The Journal of Neuroscience.

[82]  R. Treede,et al.  The role of heterosynaptic facilitation in long-term potentiation (LTP) of human pain sensation , 2008, PAIN.

[83]  M. D'Andrea,et al.  Attenuated Cold Sensitivity in TRPM8 Null Mice , 2007, Neuron.

[84]  Ron Kupers,et al.  Brain imaging of clinical pain states: a critical review and strategies for future studies , 2006, The Lancet Neurology.

[85]  J. Sandkühler,et al.  Synaptic Amplifier of Inflammatory Pain in the Spinal Dorsal Horn , 2006, Science.

[86]  Y. Nagumo,et al.  Chronic Pain Induces Anxiety with Concomitant Changes in Opioidergic Function in the Amygdala , 2006, Neuropsychopharmacology.

[87]  David Julius,et al.  TRPA1 Mediates the Inflammatory Actions of Environmental Irritants and Proalgesic Agents , 2006, Cell.

[88]  E. Nestler,et al.  The many faces of CREB , 2005, Trends in Neurosciences.

[89]  D. Clapham,et al.  Phosphatidylinositol 3-Kinase Activates ERK in Primary Sensory Neurons and Mediates Inflammatory Heat Hyperalgesia through TRPV1 Sensitization , 2004, The Journal of Neuroscience.

[90]  C. Woolf,et al.  Central sensitization and LTP: do pain and memory share similar mechanisms? , 2003, Trends in Neurosciences.

[91]  C. Woolf,et al.  Nociceptive-specific activation of ERK in spinal neurons contributes to pain hypersensitivity , 1999, Nature Neuroscience.

[92]  R. Munglani,et al.  Molecular biology of pain. , 1995, British journal of anaesthesia.

[93]  S. Irwin,et al.  The effects of morphine methadone and meperidine on some reflex responses of spinal animals to nociceptive stimulation. , 1951, The Journal of pharmacology and experimental therapeutics.

[94]  OUP accepted manuscript , 2022, Brain.

[95]  A. Patapoutian,et al.  Transient receptor potential channels: targeting pain at the source , 2009, Nature Reviews Drug Discovery.

[96]  B. Thierry,et al.  The tail suspension test: A new method for screening antidepressants in mice , 2004, Psychopharmacology.

[97]  D. Julius,et al.  The vanilloid receptor: a molecular gateway to the pain pathway. , 2001, Annual review of neuroscience.